|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 4 (February 15), 1999:
pp. 1381-1389
The t(6;8)(q27;p11) Translocation in a Stem Cell Myeloproliferative
Disorder Fuses a Novel Gene, FOP, to Fibroblast Growth
Factor Receptor 1
Cornel Popovici,
Bin Zhang,
Marie-José Grégoire,
Philippe Jonveaux,
Marina Lafage-Pochitaloff,
Daniel Birnbaum, and
Marie-Josèphe Pébusque
From the Laboratoire d'Oncologie Moléculaire, U.119 INSERM,
Institut de Cancérologie et d'Immunologie de Marseille,
Marseille, France; the Laboratoire de Biologie des Tumeurs, Institut
Paoli-Calmettes (IPC), Marseille, France; the Laboratoire de
Génétique, Centre Hospitalier Universitaire, Nancy, France;
and the Laboratoire de Cytogénétique, Département
d'Hématologie, IPC, Marseille, France.
In patients with an atypical stem-cell myeloproliferative disorder
with lymphoma (B or T cell), myeloid hyperplasia, and eosinophilia, the
chromosome 8p11-12 region is the site of a recurrent breakpoint that
can be associated with three different partners, 6q27, 9q32-34, and
13q12. Rearrangements are supposed to affect a pluripotent stem cell
capable of myeloid and lymphoid differentiation and to involve the same
8p11-12 gene. The t(8;13) translocation has recently been shown to
result in a fusion between the FGFR1 gene that encodes a
tyrosine kinase receptor for fibroblast growth factors and a novel
gene, FIM (also called RAMP or ZNF198),
belonging to a novel family of zinc finger genes. In the present study, we have cloned the t(6;8)(q27;p11) translocation in two patients and
found a fusion between FGFR1 and a novel gene, FOP
(FGFR1 Oncogene Partner), located
on chromosome band 6q27. This gene is alternatively spliced and
ubiquitously expressed. It encodes a protein containing two regions of
putative leucine-rich repeats putatively folding in  -helices and
separated by a hydrophobic spacer. The two reciprocal fusion
transcripts were evidenced by reverse transcription-polymerase chain
reaction in the tumoral cells of the patients. The
predicted chimeric FOP-FGFR1 protein contains the FOP N-terminus
leucine-rich region fused to the catalytic domain of FGFR1. It may
promote hematopoietic stem cell proliferation and leukemogenesis
through a constitutive phosphorylation and activation of the downstream
pathway of FGFR1.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Ren, X. Li, and J. K. Cowell
Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase
Blood,
August 20, 2009;
114(8):
1576 - 1584.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Goudreault, L. M. D'Ambrosio, M. J. Kean, M. J. Mullin, B. G. Larsen, A. Sanchez, S. Chaudhry, G. I. Chen, F. Sicheri, A. I. Nesvizhskii, et al.
A PP2A Phosphatase High Density Interaction Network Identifies a Novel Striatin-interacting Phosphatase and Kinase Complex Linked to the Cerebral Cavernous Malformation 3 (CCM3) Protein
Mol. Cell. Proteomics,
January 1, 2009;
8(1):
157 - 171.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Azimzadeh, P. Nacry, A. Christodoulidou, S. Drevensek, C. Camilleri, N. Amiour, F. Parcy, M. Pastuglia, and D. Bouchez
Arabidopsis TONNEAU1 Proteins Are Essential for Preprophase Band Formation and Interact with Centrin
PLANT CELL,
August 1, 2008;
20(8):
2146 - 2159.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Dong, S. Kang, T.-L. Gu, S. Kardar, H. Fu, S. Lonial, H. J. Khoury, F. Khuri, and J. Chen
14-3-3 integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells
Blood,
July 1, 2007;
110(1):
360 - 369.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-L. Gu, V. L. Goss, C. Reeves, L. Popova, J. Nardone, J. MacNeill, D. K. Walters, Y. Wang, J. Rush, M. J. Comb, et al.
Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia
Blood,
December 15, 2006;
108(13):
4202 - 4204.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. W. Finch and J. S. Rubin
Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors.
J Natl Cancer Inst,
June 21, 2006;
98(12):
812 - 824.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Yan, R. Habedanck, and E. A. Nigg
A Complex of Two Centrosomal Proteins, CAP350 and FOP, Cooperates with EB1 in Microtubule Anchoring
Mol. Biol. Cell,
February 1, 2006;
17(2):
634 - 644.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Delaval, S. Letard, H. Lelievre, V. Chevrier, L. Daviet, P. Dubreuil, and D. Birnbaum
Oncogenic Tyrosine Kinase of Malignant Hemopathy Targets the Centrosome
Cancer Res.,
August 15, 2005;
65(16):
7231 - 7240.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kim, S R Herrick, E Lemyre, S Kishikawa, J A Salisz, S Seminara, M E MacDonald, G A P Bruns, C C Morton, B J Quade, et al.
Hypogonadotropic hypogonadism and cleft lip and palate caused by a balanced translocation producing haploinsufficiency for FGFR1
J. Med. Genet.,
August 1, 2005;
42(8):
666 - 672.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tefferi and D. G. Gilliland
The JAK2V617F Tyrosine Kinase Mutation in Myeloproliferative Disorders: Status Report and Immediate Implications for Disease Classification and Diagnosis
Mayo Clin. Proc.,
July 1, 2005;
80(7):
947 - 958.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Reiter, C. Walz, A. Watmore, C. Schoch, I. Blau, B. Schlegelberger, U. Berger, N. Telford, S. Aruliah, J. A. Yin, et al.
The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2
Cancer Res.,
April 1, 2005;
65(7):
2662 - 2667.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Maeda, F. Yagasaki, M. Ishikawa, N. Takahashi, and M. Bessho
Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML
Blood,
March 1, 2005;
105(5):
2115 - 2123.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Chen, D. J. DeAngelo, J. L. Kutok, I. R. Williams, B. H. Lee, M. Wadleigh, N. Duclos, S. Cohen, J. Adelsperger, R. Okabe, et al.
PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder
PNAS,
October 5, 2004;
101(40):
14479 - 14484.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Gotlib, J. Cools, J. M. Malone III, S. L. Schrier, D. G. Gilliland, and S. E. Coutre
The FIP1L1-PDGFR{alpha} fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management
Blood,
April 15, 2004;
103(8):
2879 - 2891.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Heath and N. C. P. Cross
Critical Role of STAT5 Activation in Transformation Mediated by ZNF198-FGFR1
J. Biol. Chem.,
February 20, 2004;
279(8):
6666 - 6673.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Guasch, B. Delaval, C. Arnoulet, M.-J. Xie, L. Xerri, D. Sainty, D. Birnbaum, and M.-J. Pebusque
FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice
Blood,
January 1, 2004;
103(1):
309 - 312.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Pardanani, T. Reeder, L. F. Porrata, C.-Y. Li, H. D. Tazelaar, E. J. Baxter, T. E. Witzig, N. C. P. Cross, and A. Tefferi
Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders
Blood,
May 1, 2003;
101(9):
3391 - 3397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Guasch, C. Popovici, F. Mugneret, M. Chaffanet, P. Pontarotti, D. Birnbaum, and M.-J. Pebusque
Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3)
Blood,
January 1, 2003;
101(1):
286 - 288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Rosati, R. La Starza, A. Veronese, A. Aventin, C. Schwienbacher, T. Vallespi, M. Negrini, M. F. Martelli, and C. Mecucci
NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15)
Blood,
May 15, 2002;
99(10):
3857 - 3860.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Demiroglu, E. J. Steer, C. Heath, K. Taylor, M. Bentley, S. L. Allen, P. Koduru, J. P. Brody, G. Hawson, R. Rodwell, et al.
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins
Blood,
December 15, 2001;
98(13):
3778 - 3783.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Guasch, V. Ollendorff, J.-P. Borg, D. Birnbaum, and M.-J. Pebusque
8p12 Stem Cell Myeloproliferative Disorder: the FOP-Fibroblast Growth Factor Receptor 1 Fusion Protein of the t(6;8) Translocation Induces Cell Survival Mediated by Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt/mTOR Pathways
Mol. Cell. Biol.,
December 1, 2001;
21(23):
8129 - 8142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Emes and C. P. Ponting
A new sequence motif linking lissencephaly, Treacher Collins and oral-facial-digital type 1 syndromes, microtubule dynamics and cell migration
Hum. Mol. Genet.,
November 1, 2001;
10(24):
2813 - 2820.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. Tibiletti, B. Bernasconi, D. Furlan, P. Bressan, R. Cerutti, C. Facco, M. Franchi, C. Riva, R. Cinquetti, C. Capella, et al.
Chromosome 6 Abnormalities in Ovarian Surface Epithelial Tumors of Borderline Malignancy Suggest a Genetic Continuum in the Progression Model of Ovarian Neoplasms
Clin. Cancer Res.,
November 1, 2001;
7(11):
3404 - 3409.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Magnusson, K. E. Meade, K. E. Brown, D. C. Arthur, L. A. Krueger, A. J. Barrett, and C. E. Dunbar
Rabaptin-5 is a novel fusion partner to platelet-derived growth factor {beta} receptor in chronic myelomonocytic leukemia
Blood,
October 15, 2001;
98(8):
2518 - 2525.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. C. Hart, S. C. Robertson, and D. J. Donoghue
Identification of Tyrosine Residues in Constitutively Activated Fibroblast Growth Factor Receptor 3 Involved in Mitogenesis, Stat Activation, and Phosphatidylinositol 3-Kinase Activation
Mol. Biol. Cell,
April 1, 2001;
12(4):
931 - 942.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Chesi, L. A. Brents, S. A. Ely, C. Bais, D. F. Robbiani, E. A. Mesri, W. M. Kuehl, and P. L. Bergsagel
Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma
Blood,
February 1, 2001;
97(3):
729 - 736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kulkarni, C. Heath, S. Parker, A. Chase, S. Iqbal, C. F. Pocock, J. Kaeda, K. Cwynarski, J. M. Goldman, and N. C. P. Cross
Fusion of H4/D10S170 to the Platelet-derived Growth Factor Receptor {beta} in BCR-ABL-negative Myeloproliferative Disorders with a t(5;10)(q33;q21)
Cancer Res.,
July 1, 2000;
60(13):
3592 - 3598.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
G. Guasch, G. J. Mack, C. Popovici, N. Dastugue, D. Birnbaum, J. B. Rattner, and M.-J. Pebusque
FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33)
Blood,
March 1, 2000;
95(5):
1788 - 1796.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Bain
Eosinophilia -- Idiopathic or Not?
N. Engl. J. Med.,
October 7, 1999;
341(15):
1141 - 1143.
[Full Text]
|
|
|
|
|
|
|
V. Ollendorff, G. Guasch, D. Isnardon, R. Galindo, D. Birnbaum, and M.-J. Pebusque
Characterization of FIM-FGFR1, the Fusion Product of the Myeloproliferative Disorder-associated t(8;13) Translocation
J. Biol. Chem.,
September 17, 1999;
274(38):
26922 - 26930.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
